Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report

by Taiki Hakozaki, Yusuke Okuma, Jumpei Kashima
Published 2018-03-01

Switching administration of anti‐PD‐1 and anti‐PD‐L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non‐small cell lung cancer: Case series and...

by Shingo Kitagawa, Taiki Hakozaki, Rui Kitadai, Yukio Hosomi
Published 2020-07-01

681 Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors

by James White, Jarushka Naidoo, Jeffrey Weber, Evan Lipson, Cynthia Sears, Bertrand Routy, Fyza Shaikh, Joell Gills, Taiki Hakozaki, Richard Corentin, Yusuke Okuma, Mykhaylo Usyk, Abhishek Pandey, Jiyoung Ahn
Published 2020-11-01